comparemela.com

Latest Breaking News On - Sherbrooke park advisers - Page 1 : comparemela.com

Fund 1 Investments LLC Buys 852,330 Shares of Vera Bradley, Inc. (NASDAQ:VRA)

Fund 1 Investments LLC raised its stake in shares of Vera Bradley, Inc. (NASDAQ:VRA – Free Report) by 93.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,762,471 shares of the textile maker’s stock after buying an additional […]

Pura-vida
Vera-bradley
Tower-research-capital
Vera-bradley-inc
Sherbrooke-park-advisers
Nasdaq
Exchange-commission
Harbor-capital-advisors-inc
Vera-bradley-company-profile
Free-report
Capital-advisors
Research-capital

Olo Inc. (NYSE:OLO) CEO Sells $45,900.60 in Stock

Olo Inc. (NYSE:OLO – Get Free Report) CEO Noah H. Glass sold 10,155 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $4.52, for a total transaction of $45,900.60. Following the sale, the chief executive officer now directly owns 322,816 shares in the […]

United-states
Piper-sandler
Victory-capital-management-inc
Olo-inc
Benjaminf-edwards-company-inc
Sherbrooke-park-advisers
Rockport-wealth
Company-profile
Securities-exchange-commission
Get-free-report
Exchange-commission
Park-advisers

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]

Brucei-sachs
Reshma-kewalramani
Piper-sandler
News-ratings-for-vertex-pharmaceuticals-daily
Insider-transactions-at-vertex-pharmaceuticals
Canaccord-genuity-group
Securities-exchange-commission
Vertex-pharmaceuticals-profile
Wolfe-research
Bellevue-group
Telos-capital-management-inc
Quarter-for-vertex-pharmaceuticals

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]

Reshma-kewalramani
Brucei-sachs
Piper-sandler
Canaccord-genuity-group
Telos-capital-management-inc
Cantor-fitzgerald
Quarter-for-vertex-pharmaceuticals
Sherbrooke-park-advisers
Vertex-pharmaceuticals-stock
Insider-transactions-at-vertex-pharmaceuticals
Vertex-pharmaceuticals
Securities-exchange-commission

Bellevue Group AG Has $95.75 Million Holdings in MacroGenics, Inc. (NASDAQ:MGNX)

Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]

China
United-states
Jeffrey-stuart-peters
Stifel-nicolaus
Macrogenics-inc
Nasdaq
Sherbrooke-park-advisers
Bellevue-group
China-universal-asset-management-co
Holdings-channel
Jump-financial
Free-report

vimarsana © 2020. All Rights Reserved.